- Filed
- Mar 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 5.86M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2024 | 5.38M sh |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | $5.35M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2024 | −$9.95M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $13.94M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $12.78M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $31.12M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $34.36M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $31.61M |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $34.85M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $56.74M |
| Current Assets | Q2 2026 · Mar 31, 2025 | $59.71M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $61.39M |
| Total Assets | Q2 2026 · Mar 31, 2025 | $64.48M |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$0.01 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | −$0.42 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$0.01 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | −$0.42 |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $1.4M |
| Sga Expense restated | Q2 2026 · Sep 30, 2024 | $1.38M |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$74.29K |
| Operating Income restated | Q2 2026 · Sep 30, 2024 | $422.42K |
| Gross Profit | Q2 2026 · Sep 30, 2025 | $2.46M |
| Gross Profit restated | Q2 2026 · Sep 30, 2024 | $2.41M |
| Revenue | Q2 2026 · Sep 30, 2025 | $62.81M |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $62.84M |
| Capex | Q2 2026 · Sep 30, 2024 | $154.47K |